Management of Short Stature: Use of Growth Hormone in GH-Deficient and non-GH-Deficient Conditions

Area of Science:

• Pediatric Endocrinology
• Growth Hormone Therapy

Background:

• Growth hormone (GH) is vital for childhood somatic growth.
• Recombinant human GH availability increases its therapeutic use and potential for misuse.
• GH therapy requires strict adherence to approved indications.

Purpose of the Study:

• To outline approved pediatric indications for GH therapy.
• To emphasize the importance of patient counseling and realistic expectations.
• To discuss GH dosing, monitoring, and safety considerations.

Main Methods:

• Review of established pediatric indications for GH treatment.
• Discussion of counseling points, including goals, costs, and adverse effects.
• Emphasis on individualized dosing and titration based on patient response.

Main Results:

• Common indications include GH deficiency, Turner syndrome, Prader-Willi syndrome, SGA, renal insufficiency, and ISS.
• GH therapy has a generally good safety profile when used appropriately.
• Long-term cardiovascular effects of GH therapy warrant ongoing scrutiny.

Conclusions:

• GH therapy is indicated for specific pediatric conditions and requires careful management.
• Informed consent and realistic expectations are essential for successful treatment.
• Continuous monitoring for adverse effects, including cardiovascular risks, is necessary.